KYNTRA BIO, INC.

KYNBNasdaq· Pharmaceutical Preparations

Price History

Revenue

$6.4M

▼ 78.3% YoY

Net Income

$183.5M

▲ 485.6% YoY

EPS

$45.37

▲ 481.6% YoY

Cash

$47.9M

▼ 5.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.